1. Home
  2. INGN vs JYNT Comparison

INGN vs JYNT Comparison

Compare INGN & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INGN
  • JYNT
  • Stock Information
  • Founded
  • INGN 2001
  • JYNT 2010
  • Country
  • INGN United States
  • JYNT United States
  • Employees
  • INGN N/A
  • JYNT N/A
  • Industry
  • INGN Industrial Specialties
  • JYNT Multi-Sector Companies
  • Sector
  • INGN Health Care
  • JYNT Miscellaneous
  • Exchange
  • INGN Nasdaq
  • JYNT Nasdaq
  • Market Cap
  • INGN 186.8M
  • JYNT 149.5M
  • IPO Year
  • INGN 2014
  • JYNT 2014
  • Fundamental
  • Price
  • INGN $7.02
  • JYNT $8.41
  • Analyst Decision
  • INGN Strong Buy
  • JYNT Strong Buy
  • Analyst Count
  • INGN 3
  • JYNT 2
  • Target Price
  • INGN $11.00
  • JYNT $17.00
  • AVG Volume (30 Days)
  • INGN 210.9K
  • JYNT 143.3K
  • Earning Date
  • INGN 11-05-2025
  • JYNT 11-06-2025
  • Dividend Yield
  • INGN N/A
  • JYNT N/A
  • EPS Growth
  • INGN N/A
  • JYNT N/A
  • EPS
  • INGN N/A
  • JYNT N/A
  • Revenue
  • INGN $347,028,000.00
  • JYNT $54,176,002.00
  • Revenue This Year
  • INGN $8.12
  • JYNT $7.70
  • Revenue Next Year
  • INGN $9.02
  • JYNT $10.24
  • P/E Ratio
  • INGN N/A
  • JYNT N/A
  • Revenue Growth
  • INGN 4.68
  • JYNT 10.47
  • 52 Week Low
  • INGN $5.70
  • JYNT $7.50
  • 52 Week High
  • INGN $12.91
  • JYNT $13.47
  • Technical
  • Relative Strength Index (RSI)
  • INGN 41.91
  • JYNT 51.74
  • Support Level
  • INGN $6.92
  • JYNT $8.18
  • Resistance Level
  • INGN $7.20
  • JYNT $8.64
  • Average True Range (ATR)
  • INGN 0.27
  • JYNT 0.30
  • MACD
  • INGN 0.05
  • JYNT 0.08
  • Stochastic Oscillator
  • INGN 74.07
  • JYNT 81.16

About INGN Inogen Inc

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.

Share on Social Networks: